Balofloxacin Dihydrate (CAS 151060-21-8)

Balofloxacin dihydrate, a fluoroquinolone antibiotic, has emerged as a valuable tool in scientific research due to its unique mechanism of action and broad-spectrum antibacterial activity. Its mechanism primarily involves inhibition of bacterial DNA gyrase and topoisomerase IV enzymes, essential for DNA replication, repair, and transcription. By binding to the active site of these enzymes, balofloxacin dihydrate disrupts DNA supercoiling and strand separation, ultimately leading to bacterial cell death. This property has positioned balofloxacin dihydrate as a valuable tool in research focused on understanding bacterial DNA replication and transcription processes, as well as investigating mechanisms of fluoroquinolone resistance. Researchers leverage balofloxacin dihydrate to explore the structural and functional aspects of DNA gyrase and topoisomerase IV enzymes, as well as to explain the molecular basis of resistance mutations that confer reduced susceptibility to fluoroquinolones. Additionally, its broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria makes balofloxacin dihydrate a versatile tool for microbiological studies, including antimicrobial susceptibility testing and bacterial genetics research. Ongoing research endeavors continue to unravel the complex details of balofloxacin dihydrate′s mechanism of action and explore its potential applications in antibiotic research and microbial control methodologies.